Today: 12 June 2026
Browse Category

NASDAQ:BLTE 11 December 2025 - 30 December 2025

Belite Bio stock swings to $170 and closes up nearly 7% as rally stays hot into year-end

Belite Bio stock swings to $170 and closes up nearly 7% as rally stays hot into year-end

Belite Bio shares jumped 6.7% Monday, closing at $165.29 after trading as high as $169.75, with volume topping 309,000 shares. The move follows Dec. 1 trial results showing its oral drug tinlarebant met the main goal in Stargardt disease, and a $154-per-ADS public offering. No new company news has emerged since then. Traders are watching if gains hold as the stock trades above its recent offering price.
Belite Bio (NASDAQ: BLTE) Stock: DRAGON Trial Breakthrough, $350 Million Offering and Outlook After a 130% Rally

Belite Bio (NASDAQ: BLTE) Stock: DRAGON Trial Breakthrough, $350 Million Offering and Outlook After a 130% Rally

Belite Bio shares climbed to $154 on December 11, 2025, up over 130% year-to-date, after announcing positive Phase 3 results for tinlarebant in Stargardt disease. The company’s market value reached $5–6 billion. The DRAGON trial showed tinlarebant cut lesion growth by 36% versus placebo in adolescents with STGD1. Wall Street analysts project further upside for the stock.
11 December 2025

Stock Market Today

  • Super Micro Shares Surge 9.22% on $7 Billion AI Server Financing Plan
    June 11, 2026, 6:42 PM EDT. Super Micro Computer (NASDAQ:SMCI) shares rose 9.22% to close at $31.97 on heavy volume, driven by its $7 billion equity and equity-linked financing plan aimed at fulfilling a large AI server backlog. The move signals strong demand in AI order fulfillment but raises concerns over share dilution and legal issues. The S&P 500 gained 1.75%, and the Nasdaq climbed 2.54%, supported by gains in tech peers Dell Technologies (+5.85%) and Hewlett Packard Enterprise (+2.88%). Investors will watch execution closely, focusing on component procurement and converting AI orders into profitable revenue. Despite the rally, cautious investors note that Super Micro is not currently recommended by Motley Fool's Stock Advisor, which highlights other top stocks with stronger long-term potential.

Latest articles

AST SpaceMobile Jumps After BlueBird Launch Date News

AST SpaceMobile Jumps After BlueBird Launch Date News

12 June 2026
AST SpaceMobile shares soared 11.73% to $97.56 after confirming BlueBird satellites 8, 9, and 10 will launch June 17 on a Falcon 9, aiming to nearly double peak data speeds for its direct-to-smartphone broadband network; shares reached $101.00 after hours as investors focused on this key deployment milestone following recent volatility.
Sandisk Jumps to 52-Week High, Gains 14.5% in AI-Fueled Push

Sandisk Jumps to 52-Week High, Gains 14.5% in AI-Fueled Push

12 June 2026
Sandisk soared 14.5% to $1,881.51 after hitting a 52-week high amid a semiconductor rally, fueled by a 251% year-over-year revenue jump and bullish guidance for Q4 revenue of $7.75–$8.25 billion; Bank of America raised its price target to $2,100, citing strong memory pricing and supply contracts, as Sandisk joins the Nasdaq-100 and investors eye data-center demand and new business agreements.
Go toTop